A detailed history of Nomura Holdings Inc transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Nomura Holdings Inc holds 13,095 shares of BCYC stock, worth $192,234. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,095
Holding current value
$192,234
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.58 - $27.24 $256,400 - $356,707
13,095 New
13,095 $296,000
Q2 2023

Aug 14, 2023

BUY
$18.95 - $28.67 $7.58 Million - $11.5 Million
400,000 New
400,000 $10.2 Million

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.